Effective treatment of pancreatic neuroendocrine tumours transfected with the sodium iodide symporter gene by Re-186-perrhenate in mice

Riese, Christoph G. U. and Seitz, Stephan and Schipper, Meike L. and Behr, Thomas M. (2009) Effective treatment of pancreatic neuroendocrine tumours transfected with the sodium iodide symporter gene by Re-186-perrhenate in mice. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 36 (11). pp. 1767-1773. ISSN 1619-7070,

Full text not available from this repository. (Request a copy)

Abstract

ReO (4) (-) has similar kinetics regarding the sodium iodide symporter (NIS) to I- and TcO (4) (-) in NIS-expressing tissue. We investigated the therapeutic potential of (ReO)-Re-186 (4) (-) in NIS-transfected neuroendocrine tumour tissue. For experiments, the stably NIS-transfected pancreatic neuroendocrine cancer cell line Bon1C was used. NIS-mediated internalization and externalization experiments in vitro and a biodistribution study in nude mice bearing Bon1C xenografts were performed. A therapy study was also conducted consecutively in nude mice xenografted with Bon1C in which the mice were injected intravenously with (NaReO4)-Re-186. In vitro studies showed exponential internalization and efflux kinetics of (ReO)-Re-186 (4) (-) in the cell line. The biodistribution study showed high uptake of (ReO)-Re-186 (4) (-) in NIS-expressing tumours. Tumour growth inhibition was significant after injection of (ReO4)-Re-186 in two groups of animals treated with activity levels below the determined maximum tolerable activity as compared to controls. These results indicate that the use of (ReO)-Re-186 (4) (-) in the treatment of NIS-expressing neuroendocrine tumours is feasible and support the concept of using NIS as a therapeutic target for (ReO)-Re-186 (4) (-) .

Item Type: Article
Uncontrolled Keywords: CANCER CELL-LINES; SODIUM/IODIDE-SYMPORTER; NA+/I-SYMPORTER; IN-VIVO; SALIVARY-GLAND; BREAST-CANCER; TC-99M PERTECHNETATE; PROSTATE-CANCER; GASTRIC-MUCOSA; MAMMARY-GLAND; Sodium iodide symporter; Re-186-Perrhenate; Rhenium-186; Neuroendocrine tumours; Radionuclide therapy
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 02 Sep 2020 08:38
Last Modified: 02 Sep 2020 08:38
URI: https://pred.uni-regensburg.de/id/eprint/28183

Actions (login required)

View Item View Item